Infection of Epstein–Barr Virus is Associated with the Decrease of Helios⁺FoxP3⁺Regulatory T Cells in Active Ulcerative Colitis Patients

References

• Ciccocioppo R, Racca F, Paolucci S, Campanini G, Pozzi L, Betti E, Riboni R, Vanoli A, Baldanti F, Corazza GR. 2015. Human cytomegalovirus and Epstein–Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement. World J Gastroenterol. 21(6):1915–26. doi:10.3748/wjg.v21.i6.1915
   PubMed Web of Science ®Google Scholar
• Cohen JI. 2009. Optimal treatment for chronic active Epstein–Barr virus disease. Pediatr Transplant. 13(4):393–96.
   PubMed Web of Science ®Google Scholar
• Cui H, Cai Y, Wang L, Jia B, Li J, Zhao S, Chu X, Lin J, Zhang X, Bian Y, et al. 2018. Berberine regulates Treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon. Front Pharmacol. 9:571.
   PubMed Web of Science ®Google Scholar
• D’Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, et al. 2007. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132(2):763–86. PMID: 17258735.
   PubMed Web of Science ®Google Scholar
• da Silva BC, Lyra AC, Rocha R, Santana GO. 2014. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 20(28):9458–67.
   PubMed Web of Science ®Google Scholar
• Danese S, Fiocchi C. 2011. Ulcerative colitis. N Engl J Med. 365(18):1713–25.
   PubMed Web of Science ®Google Scholar
• Ebrahimi Daryani N, Saghazadeh A, Moossavi S, Sadr M, Shahkarami S, Soltani S, Farhadi E, Rezaei N. 2017. Interleukin-4 and interleukin-10 gene polymorphisms in patients with inflammatory bowel disease. Immunol Invest. 46(7):714–29.
   PubMed Web of Science ®Google Scholar
• Fukaura K, Iboshi Y, Ogino H, Ihara E, Nakamura K, Nishihara Y, Nishioka K, Chinen T, Iwasa T, Aso A, et al. 2018. Mucosal profiles of immune molecules related to T helper and regulatory T cells predict future relapse in patients with quiescent ulcerative colitis. Inflamm Bowel Dis. 25(6):1019–27. doi:10.1093/ibd/izy395
   Web of Science ®Google Scholar
• Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen H-R, Bruno TC, Durham NM, Hipkiss EL, Pyle KJ, Wada S, et al. 2010. A role for the transcription factor Helios in human CD4+CD25+ regulatory T cells. Mol Immunol. 47(7–8):1595–600. doi:10.1016/j.molimm.2010.02.001
   PubMed Web of Science ®Google Scholar
• Golding A, Hasni S, Illei G, Shevach EM. 2013. The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus. Arthritis Rheum. 65(11):2898–906.
   PubMedGoogle Scholar
• Harrison OJ, Powrie FM. 2013. Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol 5(7) pii:a018341–a018341. doi:10.1101/cshperspect.a018341.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang L, Chen H, Liu X, Zheng X, Shi H, Jiang L, Cui D. 2019. Analysis of regulatory T cell subsets and their expression of Helios and PD-1 in patients with Hashimoto thyroiditis. Int J Endocrinol. 2019:5368473.
   PubMed Web of Science ®Google Scholar
• Iranshahi N, Assar S, Amiri SM, Zafari P, Fekri A, Taghadosi M. 2019. Decreased gene expression of Epstein–Barr Virus-Induced Gene 3 (EBI-3) may contribute to the pathogenesis of rheumatoid arthritis. Immunol Invest. 48(4):367–77.
   PubMed Web of Science ®Google Scholar
• Keyhanmehr N, Motedayyen H, Eskandari N. 2019. The effects of silymarin and cyclosporine A on the proliferation and cytokine production of regulatory T cells. Immunol Invest. 48(5):533–48.
   PubMed Web of Science ®Google Scholar
• Li X, Chen N, You P, Peng T, Chen G, Wang J, Li J, Liu Y. 2019. The status of Epstein–Barr virus infection in intestinal mucosa of chinese patients with inflammatory bowel disease. Digestion. 99(2):126–32.
   PubMed Web of Science ®Google Scholar
• Liu C, Guan Z, Zhao L, Song Y, Wang H. 2017. Elevated level of circulating CD4+Helios+FoxP3+ cells in primary Sjogren’s syndrome patients. Mod Rheumatol. 27(4):630–37.
   PubMed Web of Science ®Google Scholar
• Lopes S, Andrade P, Conde S, Liberal R, Dias CC, Fernandes S, Pinheiro J, Simões JS, Carneiro F, Magro F, et al. 2017. Looking into enteric virome in patients with IBD: defining guilty or innocence? Inflamm Bowel Dis. 23(8):1278–84. doi:10.1097/MIB.0000000000001167
   PubMed Web of Science ®Google Scholar
• Magro F, Santos-Antunes J, Albuquerque A, Vilas-Boas F, Macedo GN, Nazareth N, Lopes S, Sobrinho-Simões J, Teixeira S, Dias CC, et al. 2013. Epstein–Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens. Inflamm Bowel Dis. 19(8):1710–16. doi:10.1097/MIB.0b013e318281f31c
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 474(7351):298–306.
   PubMed Web of Science ®Google Scholar
• Mitchell JL, Seng A, Yankee TM. 2016. Expression patterns of Ikaros family members during positive selection and lineage commitment of human thymocytes. Immunology. 149(4):400–12.
   PubMed Web of Science ®Google Scholar
• Ohkusa T, Koido S. 2015. Intestinal microbiota and ulcerative colitis. J Infect Chemother. 21(11):761–68.
   PubMed Web of Science ®Google Scholar
• Ohto U, Shibata T, Tanji H, Ishida H, Krayukhina E, Uchiyama S, Miyake K, Shimizu T. 2015. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature. 520(7549):702–05.
   PubMed Web of Science ®Google Scholar
• Paul WE. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77(9):1859–70. PMID: 2018830.
   PubMed Web of Science ®Google Scholar
• Pezhouh MK, Miller JA, Sharma R, Borzik D, Eze O, Waters K, Westerhoff MA, Parian AM, Lazarev MG, Voltaggio L, et al. 2018. Refractory inflammatory bowel disease: is there a role for Epstein–Barr virus? A case-controlled study using highly sensitive Epstein–Barr virus-encoded small RNA1 in situ hybridization. Hum Pathol. 82:187–92.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. 2018. Role of Epstein–Barr virus infection in SLE: gene-environment interactions at the molecular level. Ann Rheum Dis. 77(9):1249–50.
   PubMed Web of Science ®Google Scholar
• Rizzo AG, Orlando A, Gallo E, Bisanti A, Sferrazza S, Montalbano LM, Macaluso FS, Cottone M. 2017. Is Epstein–Barr virus infection associated with the pathogenesis of microscopic colitis? J Clin Virol. 97:1–3.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 9(5):313–23.
   PubMed Web of Science ®Google Scholar
• Ryan JL, Shen Y-J, Morgan DR, Thorne LB, Kenney SC, Dominguez RL, Gulley ML. 2012. Epstein–Barr virus infection is common in inflamed gastrointestinal mucosa. Dig Dis Sci. 57(7):1887–98.
   PubMed Web of Science ®Google Scholar
• Sartor RB. 2006. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3(7):390–407. PMID: 16819502.
   PubMedGoogle Scholar
• Shohan M, Sabzevary-Ghahfarokhi M, Bagheri N, Shirzad H, Rahimian G, Soltani A, Ghatreh-Samani M, Deris F, Tahmasbi K, Shahverdi E, et al. 2018. Intensified Th9 response is associated with the immunopathogenesis of active ulcerative colitis. Immunol Invest. 47(7):700–11. doi:10.1080/08820139.2018.1486411
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 341(6145):569–73.
   PubMed Web of Science ®Google Scholar
• Takatori H, Kawashima H, Matsuki A, Meguro K, Tanaka S, Iwamoto T, Sanayama Y, Nishikawa N, Tamachi T, Ikeda K, et al. 2015. Helios enhances treg cell function in cooperation with FoxP3. Arthritis Rheumatol. 67(6):1491–502. doi:10.1002/art.39091
   PubMed Web of Science ®Google Scholar
• Tanoue T, Atarashi K, Honda K. 2016. Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. 16(5):295–309.
   PubMed Web of Science ®Google Scholar
• Trier JS. 2002. Mucosal flora in inflammatory bowel disease: intraepithelial bacteria or endocrine epithelial cell secretory granules? Gastroenterology 123(3):955. PMID: 12198731.
   PubMed Web of Science ®Google Scholar
• Wyss A, Raselli T, Perkins N, Ruiz F, Schmelczer G, Klinke G, Moncsek A, Roth R, Spalinger MR, Hering L, et al. 2019. The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis. Mucosal Immunol. 12(3):733–45. doi:10.1038/s41385-019-0140-x
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152):427–34. PMID: 17653185.
   PubMed Web of Science ®Google Scholar
• Zafari P, Yari K, Mostafaei S, Iranshahi N, Assar S, Fekri A, Taghadosi M. 2018. Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed rheumatoid arthritis patients. Immunol Invest. 47(6):632–42.
   PubMed Web of Science ®Google Scholar
• Zagórowicz E, Bugajski M, Wieszczy P, Pietrzak A, Magdziak A, Mróz A. 2016. Cytomegalovirus infection in ulcerative colitis is related to severe inflammation and a high count of cytomegalovirus-positive cells in biopsy is a risk factor for colectomy. J Crohns Colitis. 10(10):1205–11.
   PubMed Web of Science ®Google Scholar